Introduction {#section1-2150131917696941}
============

Breast cancer is a major public health concern worldwide. It is the most prevalent cancer accounting for nearly 30% of all cancer types in women in both developed and developing countries.^[@bibr1-2150131917696941]^ The World Health Organization (WHO) estimated more than 536 521 deaths from breast cancer in 2012 worldwide.^[@bibr2-2150131917696941],[@bibr3-2150131917696941]^ Each year, nearly 1.7 million women are diagnosed with breast cancer and 522 000 die from the disease.^[@bibr2-2150131917696941]^ Furthermore, it has been estimated that almost 53% of the diagnosed breast cancer cases and 62% of breast cancer--related deaths occur in less developed regions.^[@bibr2-2150131917696941]^ This high mortality rate can be attributed to the late diagnosis of the disease.^[@bibr2-2150131917696941]^ Hence, early diagnosis of breast cancer is of paramount importance to reduce such mortality rates and the burden of breast cancer. Qatar is one of the Gulf Cooperation Council (GCC) countries with a total population of 2 258 283 (July 2016 estimate). In Qatar, breast cancer constitutes about 39% of all cancer types in females (Qatar Cancer Society website). Qatari nationals account for 32% of all breast cancer cases in Qatar (age 40-50 years).^[@bibr4-2150131917696941][@bibr5-2150131917696941]-[@bibr6-2150131917696941]^

Breast cancer screening is an efficient approach for early diagnosis and prevention of breast cancer in "high-risk" women.^[@bibr7-2150131917696941][@bibr8-2150131917696941][@bibr9-2150131917696941][@bibr10-2150131917696941]-[@bibr11-2150131917696941]^ Among the widely available risk assessment models for breast cancer, Gail model remains the most frequently used tool for prediction of the 5-year and lifetime risks of developing breast cancer for women aged 35 years and older.^[@bibr12-2150131917696941][@bibr13-2150131917696941][@bibr14-2150131917696941]-[@bibr15-2150131917696941]^ It uses 6 breast cancer risk factors, including age, hormonal or reproductive history (age at menarche and age at first live birth), previous history of breast disease (number of breast biopsies and history of atypical hyperplasia), and family history (number of first-degree relatives with breast cancer).

The Gail model^[@bibr12-2150131917696941]^ is the most widely used breast cancer risk assessment tool. An accurate assessment of individual's breast cancer risk is very important for prevention of the disease and for the health care providers to make decision on taking chemoprevention for high-risk women in clinical practice. One of the advantages of the Gail model^[@bibr12-2150131917696941]^ is the extensive validation it underwent in different female populations since its development over the past 2 decades. Despite being validated in different Western populations, Gail model validation in Arabian Gulf women has not been performed previously. The aim of this study was to assess the breast cancer risk among Arab women population in Qatar using the Gail model and provide a global comparison of risk assessment.

Subjects and Methods {#section2-2150131917696941}
====================

This is a cross-sectional study conducted at tertiary and primary health care facilities in Qatar. Data collection took place from July 2012 to June 2014, inclusive. Among the 22 primary health care centers available in Qatar, 12 were randomly selected (10 located in urban and 2 in semiurban areas). A 1-in-2 systematic sample was performed. A representative sample of 1993 women aged 35 years and older was selected. Among the 1993 invited, 1488 (74.6%) subjects gave consent to take part in this study. Each participant was informed about the study and guaranteed promises of confidentiality. The trained nurses and research assistances coordinated the face-to-face interviews with women to complete questionnaires in the Arabic language. The pilot survey instruments were initially tested for validation on 100 women. Cronbach's alpha coefficients values \>.70 indicates adequate scale reliability. Overall internal reliability (Cronbach's α = .85) was high. A structured questionnaire was used to collect sociodemographic data and details of risk factors for breast cancer such as age, age at first period, age at the first live birth, the number of previous breast biopsies, the presence of atypical hyperplasia in any previous breast biopsy specimen and history of breast cancer among the participant's first-degree relatives (mother, sisters, and daughters). The study was approved by the Research Ethical Committee of Hamad Medical Corporation and conducted in accordance with the Declaration of Helsinki. All participants signed consent form prior to inclusion in the study.

Student's *t* test was used to check significant differences between mean values of 2 continuous groups. Moreover, differences in proportions of categorical variables between 2 or more groups were ascertained by chi-square and Fisher's exact tests. Multiple linear regression models with stepwise method were used to estimate the effect of each variable on the 5-year and lifetime breast cancer risk. The level *P* \< .05 was considered as the cutoff value for significance. The Gail model risk for each subject was calculated by Breast Cancer Risk Assessment Tool (BCRAT) (an interactive tool designed for estimating the women's risk of developing invasive breast cancer).^[@bibr12-2150131917696941],[@bibr16-2150131917696941][@bibr17-2150131917696941]-[@bibr18-2150131917696941]^

The Gail model calculates the probability of a woman at age *a* who has age-related relative risk *r*(*t*). This will develop breast cancer by age $a + \tau$.

$$p\left\{ {a,\tau,r(t)} \right\} = {\int\limits_{a}^{a + \tau}{h_{1}(t)}}r(t)e^{- {\int\limits_{a}^{\tau}{h_{1}(u)r(u)du}}}\left\{ {S_{2}(t)/S_{2}(a)} \right\} dt$$

where $S_{2}(t) = e^{- {\int\limits_{0}^{t}{h_{2}(u)du}}}$. It is the probability of surviving competing risk up to age. In this equation, $h_{1}(t)$ denotes the age-related risk of a subject from unknown risk factors and $h_{2}(t)$ refers to the age-related risk of causes of death.^[@bibr12-2150131917696941]^

BCRAT calculated 4 types of risk, including 5-year risk, lifetime risk, average 5-year risk, and lifetime risk for each women of same age. To stratify women into high-risk category is one of the main purposes of using breast cancer risk tools. Accordingly, health care provider can provide better screening decision or clinical management strategies for individual patient.^[@bibr17-2150131917696941]^ Using the Gail model, as a golden standard, a woman with a probability of getting breast cancer of less than 1.66% in 5 years is considered being at low risk. Conversely, a woman with a probability of more than 1.66% is classified as high-risk and should undergo intensive screening by annual mammography and clinical breast examination every 6 to 12 months.^[@bibr19-2150131917696941]^

Inclusion Criteria {#section3-2150131917696941}
------------------

Women of Qatar and Arab nationals aged 35 years or older were included in the current study. Subjects with prior history of breast cancer and mentally-incapacitated patients were excluded from the study.

Results {#section4-2150131917696941}
=======

[Table 1](#table1-2150131917696941){ref-type="table"} shows the sociodemographic characteristics of all reported women (N = 1488). The mean age of the women in the study was 47.7 ± 10.2 years. Qatari nationals constituted 64.7% of participants whereas 35.3% were Arab expatriates. Around 86 % of participants were married women, 14.6% were illiterate, 23.9% were university graduates, and 53% were housewives. The age of menarche for the majority of participants (57.6%) was between 12 and 13 years. Majority of participants (60.6%) were postmenopausal women. Interestingly, *sheesha* smoking habit was more popular in Arab women (9.7%) than cigarette smoking (4.8%).

###### 

Sociodemographic Characteristics of Breast Cancer Patients (N = 1488).

![](10.1177_2150131917696941-table1)

  Characteristic                  n                     \%
  ------------------------------- --------------------- ------
  Age, years, mean ± SD (range)   47.8 ± 10.8 (35-65)   
  Age group, years                                      
   35-45                          468                   31.5
   46-55                          528                   37.5
   56-65                          462                   31.0
  Ethnicity                                             
   Qatari                         963                   64.7
   Other Arabs                    526                   35.3
  Age at menarche, years                                
   9-11                           274                   18.4
   12-13                          857                   57.6
   ≥14                            357                   24.0
  Menopausal                                            
   Premenopausal (nonmenopause)   586                   39.4
   Postmenopausal (menopause)     902                   60.6
  Marital status                                        
   Single                         67                    13.9
   Married                        1329                  86.1
   Widowes/divorced               92                    6.1
  Education level                                       
   Illiterate                     211                   14.2
   Primary                        282                   19.0
   Intermediate                   256                   17.2
   Secondary                      384                   25.8
   University or higher           355                   23.9
  Occupation                                            
   Housewife                      789                   53.0
   Sedentary/Professional         298                   20.0
   Clerk/Officer/Administrator    235                   15.8
   Businesswoman                  86                    5.8
   Police/Army/Security force     80                    5.4
  Household income                                      
   Low                            504                   33.9
   Medium                         624                   41.9
   High                           360                   24.2
  Smoking                                               
   Yes                            72                    4.8
   No                             1416                  95.2
  Sheesha smoking                                       
   Yes                            144                   9.7
   No                             1344                  90.3

[Table 2](#table2-2150131917696941){ref-type="table"} presents the lifestyle and clinical characteristics of the study population. Daily physical activity was less practiced among participants during hot seasons, only 27.5% walked 30 minutes per day and 12% walked 60 minutes per day. Around 43% of women were overweight and 30% were obese. Majority of women had one child. Consanguineous marriage among parents was observed in 30.6% of the studied women. Most of the women in this study (67.7%) breast-fed their children more than 6 months.

###### 

Lifestyle and Clinical Characteristics of Study Sample (N = 1488).

![](10.1177_2150131917696941-table2)

  Variables                            Frequency and Percentage, n (%)
  ------------------------------------ ---------------------------------
  Physical activity, walking per day   
   30 minutes                          409 (27.5)
   60 minutes                          178(12.0)
   None                                901 (60.5)
  Body mass index group, kg/m^2^       
   20-24.99 (normal)                   405 (27.2)
   25-30 (overweight)                  637 (42.8)
   \>30 (obese)                        446 (30.0)
  Infertility                          
   Yes                                 106 (7.1)
   No                                  1382 (92.9)
  Parity                               
   None                                121 (8.1)
   1 child                             422 (28.4)
   2-3 children                        353 (23.7)
   4-5 children                        311 (20.9)
   \>6 children                        281 (18.9)
  Breast-feeding                       
   Yes                                 1220 (82.0)
   No                                  268 (18.0)
  Breast-feeding duration              
   ≤6 months                           376 (25.3)
   \>6 months                          1006 (67.7)
  None                                 106 (7.1)
  Consanguineous parents               
   Yes                                 456 (30.6)
   No                                  1032 (69.4)
  First-degree family cancer history   
   Yes                                 203 (13.6)
   No                                  1285 (86.4)
  Family cancer history more than 1    
   Yes                                 90 (6)
   No                                  1398 (94)
  Mammography screening                
   Yes                                 107 (8)
   No                                  1231 (92.0)

[Table 3](#table3-2150131917696941){ref-type="table"} shows the sociodemographic characteristics of women with breast cancer risk using Gail model for 5-year and lifetime risk of breast cancer. The women who had a medical history of breast cancer and mutation of BRAC1 or BRAC2 genes were excluded and there were 1338 women remaining. The mean 5-year and lifetime risks for breast cancer were 1.12 ± 0.52 and 10.57 ± 3.1, respectively. The mean 5-year and lifetime risks for women of the same age were 1.15 ± 0.46 and 11.04 ± 1.21, respectively. The 5-year and lifetime risks were considered as low if they were lower than their mean value. Similarly, the 5-year and lifetime risks were considered as high if they were higher than their mean value. We found a relationship between the 5-year and lifetime risks of breast cancer and variables such as age, age at menarche, gravidity, parity, body mass index (BMI), family history of cancer, menopause age, occupation, and level of education.

###### 

Sociodemographic Characteristics of Patients With Breast Cancer Risk Using the Gail Model (N = 1338).

![](10.1177_2150131917696941-table3)

                              5-Year Risk   Lifetime Risk                                      
  --------------------------- ------------- --------------- -------- ------------ ------------ --------
  Age group, years                                                                             
   35-45                      445 (60.0)    22 (3.7)                 160 (21.8)   307 (50.9)   
   46-55                      257 (34.6)    278 (46.6)      \<.001   310 (42.2)   225 (37.3)   \<.001
   56-65                      40 (5.4)      296 (49.7)               265 (36)     71 (11.8)    
  Ethnicity                                                                                    
   Qatari                     515 (69.4)    419 (70.3)      .723     519 (70.6)   415 (68.8)   .478
   Other Arabs                227 (30.6)    177 (29.7)               216 (29.4)   188 (31.2)   
  Age at Menarche, years                                                                       
   9-11                       112 (15.1)    115 (19.3)               105 (14.3)   122 (20.2)   
   12-13                      437 (58.9)    346 (58.1)      .082     405 (55.1)   378 (62.7)   \<.001
   ≥14                        193 (26.0)    135 (22.7)               225 (30.6)   103 (17.1)   
  Age at first birth, years                                                                    
   \<20                       94 (12.7)     5 (0.8)                  94 (12.8)    5 (0.8)      
   20-24                      256 (34.5)    91 (15.3)       \<.001   299 (40.7)   48 (8.0)     \<.001
   25-29                      223 (30.1)    196 (32.9)               258 (35.1)   161 (26.7)   
   ≥30                        169 (22.8)    304 (64.3)               84 (11.4)    389 (29.1)   
  Family history                                                                               
   Yes                        35 (4.7)      115 (19.3)      \<.001   8 (1.1)      142 (23.5)   \<.001
   No                         707 (95.3)    481 (80.7)               727 (98.9)   461 (76.5)   
  Menopausal                                                                                   
   Premenopausal              484 (65.2)    37 (6.2)        \<.001   194 (26.4)   327 (54.2)   \<.001
   Postmenopausal             258 (34.8)    559 (93.8)               541 (73.6)   276 (45.8)   
  Breast-feeding                                                                               
   \<6 months                 150 (20.2)    110 (18.5)      .419     151 (20.5)   109 (18.1)   .256
   ≥6 months                  592 (79.8)    486 (81.5)               584 (79.5)   494 (81.9)   
  Consanguinity                                                                                
   Yes                        225 (30.3)    181 (30.4)      .986     214 (29.1)   192 (31.8)   .281
   No                         517 (69.7)    415 (69.6)               521 (70.1)   411 (68.2)   
  Parity                                                                                       
   ≤3 children                570 (76.8)    429 (72.0)      .043     540 (73.5)   459 (76.1)   .267
   \>3 children               172 (23.2)    167 (28.0)               195 (26.5)   144 (23.9)   
  Body mass index, kg/m^2^                                                                     
   20-24.99                   222 (29.9)    138 (23.2)               191 (26.0)   169 (28.0)   
   25-30                      277 (37.3)    304 (51.0)      \<.001   332 (45.2)   249 (41.3)   .361
   \>30                       243 (32.7)    154 (25.8)               212 (28.8)   185 (30.7)   
  Breast biopsies                                                                              
   Yes                        4 (0.5)       8 (1.3)                  5 (0.7)      7 (1.2)      
   No                         738 (99.5)    588 (98.7)      .149     730 (99.3)   596 (98.8)   .394
  Sheesha smoking                                                                              
   Yes                        76 (10.2)     60 (10.1)       .916     66 (9.0)     70 (11.6)    .113
  Occupation                                                                                   
   Housewife                  362 (48.8)    341 (57.2)               380 (51.7)   323 (53.6)   
   Sedentary/Professional     206 (27.8)    63 (10.6)       \<.001   129 (17.6)   140 (23.2)   .001
   Clerk/Administrator        137 (18.5)    149 (25)                 182 (24.8)   104 (17.2)   
   Businesswoman              37 (5.0)      43 (7.2)                 44 (6.0)     36 (6.0)     
  Education level                                                                              
   Illiterate                 71 (9.6)      118 (19.8)               117 (15.9)   72 (11.9)    
   Primary                    132 (17.8)    126 (21.1)               133 (18.1)   125 (20.7)   
   Intermediate               105 (14.2)    127 (21.3)      \<.001   135 (18.4)   97 (16.1)    .019
   Secondary                  202 (27.2)    140 (23.5)               196 (26.7)   146 (24.2)   
   University or higher       232 (31.3)    85 (14.3)                154 (21.0)   163 (27.0)   

[Table 4](#table4-2150131917696941){ref-type="table"} shows the general linear regression model analysis as predictors for 5-year and lifetime risks of developing breast cancer in women 35 years and older in the state of Qatar. The linear regression analysis identified the predictors for breast cancer in women for 5-year and lifetime risks such as age, age at menarche, age of first birth, family history, and age of menopause were considered the strong predictors and significant contributing risk factors for breast cancer after adjusting for ethnicity, parity, and other variables (*P* \< .001). Meanwhile the model and analysis did not have significant affect for breast-feeding, consanguinity, BMI, sheesha smoking, smoking, occupation, and education level; however, did not enter into the model as predictors.

###### 

Regression Results for 5-Year and Lifetime Gail Risk.

![](10.1177_2150131917696941-table4)

  Independent Variables   Coefficient   Standard Error   *t*       *P*
  ----------------------- ------------- ---------------- --------- --------
  5-year risks                                                     
   Constant               −0.519        0.063            −8.222    \<.001
   Age                    0.055         0.001            50.735    \<.001
   Age at menarche        −0.039        0.003            −13.036   \<.001
   Age of first birth     0.034         0.001            37.682    \<.001
   Family history         −0.734        0.014            −51.293   \<.001
   Menopause              0.062         0.018            3.499     \<.001
  Lifetime risks                                                   
   Constant               25.055        0.430            58.229    \<.001
   Age                    −0.161        0.007            −21.622   \<.001
   Age at menarche        −0.322        0.021            −15.692   \<.001
   Age of first birth     0.315         0.006            51.732    \<.001
   Family history         −6.087        0.097            −62.432   \<.001
   Menopause              −0.221        0.121            −1.831    .067

Globally reported Gail's breast cancer risks are presented in [Table 5](#table5-2150131917696941){ref-type="table"}. The Gail model overestimates risk in most of the studies apart from the United States, because the risk factors and incidence rates of breast cancer are varied across different ethnicities.

###### 

Reported Gail's Breast Cancer Risk: Global Variations and Comparisons.

![](10.1177_2150131917696941-table5)

  Study                                              Year   Country          Sample Size (n)   Study Design Type   Age (Years)   5-Year Breast Cancer Risk   Lifetime Breast Cancer Risk
  -------------------------------------------------- ------ ---------------- ----------------- ------------------- ------------- --------------------------- -----------------------------
  Gail et al^[@bibr12-2150131917696941]^             1989   USA              4496              Case-control        \>50          1.02                        11.21
  Ulusoy et al^[@bibr9-2150131917696941]^            2010   Turkey           650               Cross-sectional     \>35          1.67                        7.70
  Khazaee-Pool et al^[@bibr14-2150131917696941]^     2016   Iran             3847              Cross-sectional     \>35          1.61                        11.71
  Erbil et al^[@bibr20-2150131917696941]^            2015   Turkey           231               Cross-sectional     \>35          0.88                        9.37
  Seyednoori et al^[@bibr13-2150131917696941]^       2012   Iran             314               Cross-sectional     \>35          0.80                        9.0
  Yilmaz et al^[@bibr10-2150131917696941]^           2011   Turkey           415               Cross-sectional     \>20          1.70                        15.0
  Khaliq et al^[@bibr11-2150131917696941]^           2016   USA              124               Cross-sectional     \>50          1.67                        ---
  Eadie et al^[@bibr16-2150131917696941]^            2013   UK               355               Cross-sectional     \>46          1.50                        9.0
  Tice et al^[@bibr21-2150131917696941]^             2005   USA              8,388             Cross-sectional     \>18          0.80                        8.0
  Baitchev et al^[@bibr8-2150131917696941]^          2009   Bulgaria         315               Retrospective       \>35          1.51                        ---
  Challa et al^[@bibr22-2150131917696941]^           2013   India            200               Case-control        \>35          ---                         7.80
  Mirgahfourvand et al^[@bibr23-2150131917696941]^   2016   Iran             560               Cross-sectional     \>35          0.60                        8.90
  Abu Rustum et al^[@bibr7-2150131917696941]^        2001   USA              319               Prospective         \>35          1.67                        ---
  Park et al^[@bibr24-2150131917696941]^             2013   Korea            3789              Cohort              \<50          0.44                        2.24
  Davids et al^[@bibr25-2150131917696941]^           2004   USA              254               Cross-sectional     \>40          1.50                        8.40
  Ewaid and Al-Azzawi^[@bibr15-2150131917696941]^    2016   Iraq             250               Cross-sectional     \>35          0.95                        11.30
  Novotny et al^[@bibr26-2150131917696941]^          2006   Czech Republic   4598              Case-control        \>35          1.37                        8.02
  Adams-Campbell et al^[@bibr27-2150131917696941]^   2009   USA              883               Retrospective       \>40          0.88                        ---
  Panahi et al^[@bibr28-2150131917696941]^           2008   Iran             2000              Cross-sectional     \>35          0.92                        9.14
  Palomares et al^[@bibr29-2150131917696941]^        2006   USA              99                Prospective         \>35          4.13                        23.50
  Bener et al (present study)                        2016   Qatar            1488              Cross-sectional     \>35          1.12                        10.57

Discussion {#section5-2150131917696941}
==========

Breast cancer in Qatar is the most common form of cancer in Qatari Arab women and the most frequent cause of cancer-related death.^[@bibr4-2150131917696941],[@bibr5-2150131917696941],[@bibr30-2150131917696941]^ Hence, an accurate assessment of individual's breast cancer risk is of paramount importance to patients as well as health care providers to make decision on taking chemoprevention for high-risk women. It is important to know that the women at high risk of developing breast cancer need valuable supports for making a decision in health care and accepting the effect of different prevention policies.

Various mathematical models are widely available to estimate individual breast cancer risk. For the past 2 decades, the Gail model has been considered to be the best available means for estimating risk of development of breast cancer.^[@bibr12-2150131917696941],[@bibr17-2150131917696941],[@bibr18-2150131917696941]^ It is also the most frequently used model in chemoprevention trials and counseling. The original model was derived from general American white women with annual mammography screening^[@bibr12-2150131917696941],[@bibr17-2150131917696941]^ and hence, it can be suitable for populations such as in the current study and other similar studies.^[@bibr13-2150131917696941][@bibr14-2150131917696941]-[@bibr15-2150131917696941],[@bibr20-2150131917696941]^ Nevertheless, one of the important limitations of Gail model is the lack of consideration of breast cancer among second degree-relatives as a risk factor. Furthermore, a number of previous studies have shown that the Gail model may overestimate the risk of development of breast cancer.^[@bibr7-2150131917696941],[@bibr21-2150131917696941],[@bibr27-2150131917696941]^ The Claus model (1998) on the other hand, focuses on presence of first- and second-degree relatives with breast cancer and their age at diagnosis as important risk factors. Unlike the Gail and Claus models,^[@bibr32-2150131917696941]^ the BRCAPRO model uses Mendelian approaches and Bayesian statistics and takes into consideration family history of bilateral breast cancer and ovarian cancer. The Tyrer-Cuzick model^[@bibr33-2150131917696941]^ (IBIS model) assesses 10-year risk and presents a non-BRCA1/BRCA2 breast cancer susceptibility gene mutation for individuals. However, the limitation of this model is to collect unaffected relatives and type of benign disease.

The Gail model has not been validated in female population of the Gulf Cooperation Council (GCC) countries. To the best of our knowledge, the current study is the first to evaluate the performance of the Gail model for Arab women population in the GCC. Furthermore, we studied the effects of factors that were not included in the Gail model such as consanguinity, BMI, menopausal and postmenopausal status, duration of breast-feeding on the risk of developing breast cancer. In agreement with other studies,^[@bibr5-2150131917696941],[@bibr31-2150131917696941],[@bibr34-2150131917696941],[@bibr35-2150131917696941]^ the current study revealed that the general risk of breast cancer was high in single women, women with a positive family history of breast cancer, and women who did not breast-feed their children. The risk was higher with lower menarche ages, higher level of education and higher women's age at first childbirth. We also found that certain factors could lower the risk of breast cancer such as multiparity, breast-feeding history, and absence of family history of breast cancer.

Our study has a number of limitations. The cross-sectional nature of the study does not allow future assessment and update regarding changes in the various risk factors among the participants. Moreover, bias may affect the results due to self-reported data; however, this study was based on face-to-face interviews and randomly we checked 50% of women's medical records for accuracy. Furthermore, we did not examine the genetic susceptibilities of the study population as well as the association between history of other malignancies (such as ovarian cancer) and the risk of development of breast cancer.

Conclusion {#section6-2150131917696941}
==========

Breast cancer is an important health problem in Qatar and estimating risk of development of breast cancer in Qatari and Arab nationals is very important for screening and prevention of the disease. The current study highlights the usefulness of Gail model as important breast cancer risk prediction model for clinical decision making. The Gail model is an appropriate breast cancer risk assessment tool for Qatari's female population. The breast cancer risk assessment can be helpful in the clinical management of screening and prevention.
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